Global challenges keynote address in memoriam to colleagues lost in the Malaysia airlines 17 crash

References

• ANRS. (2015, November). A huge advance in the fight against AIDS: France approves HIV pre-exposure prophylaxis for HIV. Press Release. Retrieved from http://www.anrs.fr/VIH-SIDA/Sante-publique-Sciences-sociales/Actualites/UN-IMMENSE-PROGRES-DANS-LA-LUTTE-CONTRE-LE-SIDA
   Google Scholar
• Bärnighausen, T. (2015). The HIV treatment cascade and antiretroviral impact in different populations. Current Opinion in HIV and AIDS, 10(6), 391–394. http://doi.org/10.1097/COH.0000000000000205
   PubMed Web of Science ®Google Scholar
• Beyond aid: Financing Development. (2015). The economist. Retrieved from http://www.economist.com/news/leaders/21657389-unheralded-meeting-africa-way-get-beyond-sterile-arguments-about-development-beyond#b07g20t20w15
   Google Scholar
• Burton, D. R., Ahmed, R., Barouch, D. H., Butera, S. T., Crotty, S., Godzik, A., … Wyatt, R. (2012). A Blueprint for HIV Vaccine Discovery. Cell Host & Microbe, 12(4), 396–407. http://doi.org/10.1016/j.chom.2012.09.008 doi: 10.1016/j.chom.2012.09.008
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … HPTN 052 study team. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine, 365(6), 493–505. http://doi.org/10.1056/NEJMoa1105243 doi: 10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• DREAMS: Working Together for an AIDS-free Future for Girls. (2015). PEPFAR. Retrieved from http://www.pepfar.gov/documents/organization/245534.pdf
   Google Scholar
• FDA. (2012). FDA, Press release: FDA approves first drug for reducing the risk of sexually acquired HIV infection. Silver Spring: US Food and Drug Administration. Retrieved from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.htm
   Google Scholar
• Gates, B. (2015, July 22). For poor countries … . [Twitter]. Retrieved from https://twitter.com/billgates/status/623982190750269443
   Google Scholar
• Gilead Sciences, Inc. (2015, December 23). Statement on approval of PrEP by Kenya's Pharmacy and Poisons Board.
   Google Scholar
• Hankins, C. A., & de Zalduondo, B. O. (2010). Combination prevention: A deeper understanding of effective HIV prevention. AIDS, 24(Suppl 4), S70–S80. http://doi.org/10.1097/01.aids.0000390709.04255.fd doi: 10.1097/01.aids.0000390709.04255.fd
   PubMed Web of Science ®Google Scholar
• Hill, A. (2015, April). Generics – the facts. Presented at the British HIV Association Conference, Brighton, England. Retrieved from http://www.bhiva.org/documents/Conferences/2015Brighton/Presentations/150422/AndrewHill.pdf
   Google Scholar
• INSIGHT START Study Group, Lundgren, J. D., Babiker, A. G., Gordin, F., Emery, S., Grund, B., … Neaton, J. D. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine, 373(9), 795–807. http://doi.org/10.1056/NEJMoa1506816 doi: 10.1056/NEJMoa1506816
   PubMed Web of Science ®Google Scholar
• International Drug Policy Consortium. (2015). Retrieved from http://idpc.net/policy-advocacy/drug-policy-reform
   Google Scholar
• International Partnership for Microbicides. (n.d.). The Ring study. Retrieved from http://www.ipmglobal.org/the-ring-study
   Google Scholar
• Jewkes, R. K., Dunkle, K., Nduna, M., & Shai, N. (2010). Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: A cohort study. The Lancet, 376(9734), 41–48. http://doi.org/10.1016/S0140-6736(10)60548-X doi: 10.1016/S0140-6736(10)60548-X
   PubMed Web of Science ®Google Scholar
• Kates, J., Wexler, A., & Lief, E. (2015, July). Financing the response to HIV in low- and middle-income countries: International assistance from donor governments in 2014. The Henry J Kaiser Family Foundation.
   Google Scholar
• Ledgerwood, J. E., Coates, E. E., Yamshchikov, G., Saunders, J. G., Holman, L., Enama, M. E., … VRC 602 Study Team. (2015). Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults. Clinical and Experimental Immunology, 182(3), 289–301. http://doi.org/10.1111/cei.12692 doi: 10.1111/cei.12692
   PubMed Web of Science ®Google Scholar
• Lewin, S. R. (2013). A cure for HIV: Where we've been, and where we're headed. Lancet, 381(9883), 2057–2058. http://doi.org/10.1016/S0140-6736(13)61180-0 doi: 10.1016/S0140-6736(13)61180-0
   PubMed Web of Science ®Google Scholar
• McLean, R. (2015, July). Sustainable and transitional financing and resource allocation for HIV and AIDS health financing in the Caribbean. Presented at the 8th IAS conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, Canada.
   Google Scholar
• McNairy, M. L., & El-Sadr, W. M. (2014). A paradigm shift: Focus on the HIV prevention continuum. Clinical Infectious Diseases, 59(suppl 1), 12–15. http://doi.org/10.1093/cid/ciu251 doi: 10.1093/cid/ciu251
   Web of Science ®Google Scholar
• Medicines Control Council, S. A. (2015, December). Medicines control council approves fixed-dose combination of tenofovir disoproxyl fumarate and emtricitabine for pre-exposure prophylaxis of HIV. Press Release. Retrieved from http://www.mccza.com/documents/2e4b3a5310.11_Media_release_ARV_FDC_PrEP_Nov15_v1.pdf
   Google Scholar
• Microbicide Trials Network. (n.d.). ASPIRE. Retrieved 4 January 2016, from http://www.mtnstopshiv.org/news/studies/mtn020/backgrounder
   Google Scholar
• Microbicides Trials Network. (n.d.). MTN-017: Phase II safety and acceptability study of tenofovir gel reformulated for rectal use. Retrieved from http://www.mtnstopshiv.org/news/studies/mtn017/backgrounder
   Google Scholar
• Morbidity and Mortality Weekly Report. (2015, May 1). Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone – Indiana, 2015. Retrieved from www.cdc.gov/mmwr/pdf/wk/mm6416.pdf
   Google Scholar
• Muchiri, S. (2015, July). Financing and Resource Allocation for HIV in Kenya. Presented at the International Conference on HIV, Vancouver, Canada.
   Google Scholar
• Nabel, G. J. (2013). Designing tomorrow's vaccines. The New England Journal of Medicine, 368(6), 551–560. http://doi.org/10.1056/NEJMra1204186 doi: 10.1056/NEJMra1204186
   PubMed Web of Science ®Google Scholar
• Piot, P., Abdool Karim, S. S., Hecht, R., Legido-Quigley, H., Buse, K., Stover, J., … Sidibé, M. (2015). Defeating AIDS – advancing global health. The Lancet, 386(9989), 171–218. http://doi.org/10.1016/S0140-6736(15)60658-4 doi: 10.1016/S0140-6736(15)60658-4
   PubMed Web of Science ®Google Scholar
• Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., … MOPH-TAVEG Investigators. (2009). Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. The New England Journal of Medicine, 361(23), 2209–2220. http://doi.org/10.1056/NEJMoa0908492 doi: 10.1056/NEJMoa0908492
   PubMed Web of Science ®Google Scholar
• Russian HIV-Aids epidemic worsening under Kremlin policies, says expert. (2015, May 15). The Guardian. Retrieved from http://www.theguardian.com/world/2015/may/15/russian-hiv-aids-epidemic-worsening-under-kremlin-policies-says-expert
   Google Scholar
• Sarafis, P., & Tsounis, A. (2014). Debt burden of Greece and HIV among injecting drug users. The Lancet Infectious Diseases, 14(3), 180–181. http://doi.org/10.1016/S1473-3099(14)70017-9 doi: 10.1016/S1473-3099(14)70017-9
   PubMed Web of Science ®Google Scholar
• Spreen, W., Williams, P., Margolis, D., Ford, S. L., Crauwels, H., Lou, Y., … Piscitelli, S. (2014). Pharmacokinetics, safety, and tolerability with repeat doses of GSK1265744 and rilpivirine (TMC278) long-acting nanosuspensions in healthy adults. Journal of Acquired Immune Deficiency Syndromes (1999), 67(5), 487–492. http://doi.org/10.1097/QAI.0000000000000365 doi: 10.1097/QAI.0000000000000365
   PubMed Web of Science ®Google Scholar
• The TEMPRANO ANRS 12136 Study Group. (2015). A trial of early antiretrovirals and isoniazid preventive therapy in Africa. New England Journal of Medicine, 373(9), 808–822. http://doi.org/10.1056/NEJMoa1507198 doi: 10.1056/NEJMoa1507198
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2014a). Fast track: Ending the AIDS epidemic by 2030. Retrieved from http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf
   Google Scholar
• UNAIDS. (2014b, September). 2014 Progress report on the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Retrieved from http://www.unaids.org/en/resources/documents/2014/JC2681_2014-Global-Plan-progress
   Google Scholar
• UNAIDS. (2015a). Fast-tracking combination prevention: Towards reducing new HIV infections to fewer than 500 000 by 2020. Joint United Nations Programme on HIV/AIDS.
   Google Scholar
• UNAIDS. (2015b). How AIDS changed everything. Retrieved from http://www.unaids.org/sites/default/files/media_asset/MDG6Report_en.pdf
   Google Scholar
• Vassall, A. (2015, July). New fiscal space challenges in sub-Saharan Africa. Presented at the 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, Canada.
   Google Scholar
• World Health Organization. (2012). Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV. Recommendations for use in the context of demonstration projects. Retrieved from http://www.who.int/hiv/pub/guidance_prep/en/index.html
   Google Scholar
• World Health Organization. (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organisation. Retrieved from http://www.who.int/hiv/pub/guidelines/arv2013/en/
   Google Scholar
• World Health Organization. (2015a). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Retrieved from http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf
   Google Scholar
• World Health Organization. (2015b, May). Consolidated strategic information guidelines for HIV in the health sector. Retrieved from http://www.who.int/hiv/pub/guidelines/strategic-information-guidelines/en/
   Google Scholar
• World Health Organization. (2015c, July). Consolidated guidelines on HIV testing. Retrieved from http://apps.who.int/iris/bitstream/10665/179870/1/9789241508926_eng.pdf?ua=1&ua=1
   Google Scholar